Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3098)
All Articles published online
|
Publishing Process of This Article
|
May 16, 2022 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huguenot M, Bruhm AC, Essig M. Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report. World J Clin Cases 2022; 10(14): 4502-4508 [PMID: 35663093 DOI: 10.12998/wjcc.v10.i14.4502] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i14/4502.htm |
| Number | Citing Articles |
| 1 |
Benyu Yang, Wenhan Li, Yiqiang Gao, Bo Zhang, Wei Zuo. Off-Label Use of Monoclonal Antibodies for Eosinophilic Esophagitis in Humans: A Scoping Review. Biomedicines 2024; 12(11): 2576 doi: 10.3390/biomedicines12112576
|
| 2 |
Azusa Ishii, Tomofumi Shibata, Yohei Tsunoda, Takafumi Kayukawa, Masahiro Kobayashi, Masami Orinaka, Shoko Miyamatsu, Yoshio Ryuge, Shuichi Asano, Ichidai Tanaka. Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report. BMC Geriatrics 2024; 24(1) doi: 10.1186/s12877-024-04683-1
|
| 3 |
Patrick D. Meek, Brian Hemstreet. Emerging therapies for eosinophilic esophagitis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2023; 43(4): 338 doi: 10.1002/phar.2783
|
| 4 |
Carlo Lombardi, Pasquale Comberiati, Erminia Ridolo, Marcello Cottini, Mona Rita Yacoub, Silvia Casagrande, Matteo Riccò, Marco Bottazzoli, Alvise Berti. Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan. Drugs 2024; 84(6): 661 doi: 10.1007/s40265-024-02037-0
|
| 5 |
Margarida Gomes, Ana Mendes, Filipa Ferreira, Joana Branco, Fernanda S. Tonin, M. Elisa Pedro, Piotr K. Janicki. The Role of Benralizumab in Eosinophilic Immune Dysfunctions: A Case Report-Based Literature Review. Case Reports in Medicine 2023; 2023: 1 doi: 10.1155/2023/8832242
|
| 6 |
Quan M. Nhu, Seema S. Aceves. Current state of biologics in treating eosinophilic esophagitis. Annals of Allergy, Asthma & Immunology 2023; 130(1): 15 doi: 10.1016/j.anai.2022.10.004
|